An Updated Review On Analytical Methods For Estimation Of Azelnidipine And Telmisartan

  • M. M. Eswarudu Department of Pharmaceutical Analysis, Vignan Pharmacy College, Vadlamudi 522213, Andhra Pradesh, India
  • P. Roja Department of Pharmaceutical Analysis, Vignan Pharmacy College, Vadlamudi 522213, Andhra Pradesh, India
  • P. Ravi Sankar Department of Pharmaceutical Analysis, Vignan Pharmacy College, Vadlamudi 522213, Andhra Pradesh, India
  • P. Srinivasa Babu Department of Pharmaceutical Analysis, Vignan Pharmacy College, Vadlamudi 522213, Andhra Pradesh, India

Abstract

High blood pressure, also called hypertension, is a common condition that is characterized by having a higher amount of pressure in blood vessels than normal. Hypertension (HT) is a very common disorder, particularly past middle age. It is not a disease in itself, but is an important risk factor for cardiovascular mortality and morbidity. For improvement activity of hypertension, Azelnidipine and Telmisartan newer combination in market, which is effective in Hypertension. This combination was developed to improve medication for Stage II Hypertension. Azelnidipine is Ca2+ channel blocker and chemically 3-[1-(Benzyldrylazetidin-3-yl] 5-isopropyl- 2- amino 6 methyl-4-(3-nitrophenyl)-1,4- dihydropyridine-3, 5dicarboxylate.Telmisartan is AT1-receptor blocker and Chemically2-{4-[[4-methyl-6-(1-methylbenzimidazol-2yl)-2–propylbenzimidazol-1yl] methyl] biphenyl)-benzoic acid. It provides information about different analytical method development like UV spectrophotometry, HPTLC, HPLC, and LC-MS methods reported for Azelnidipine and Telmisartan for individual and other drug combination. All reported methods found to be simple, accurate, economic, precise and reproducible in nature. This Review focuses on recent development in analytical method development for Azelnidipine and Telmisartan, and there were two methods reported for this combination as per our knowledge.


 

Keywords: Azelnidipine, Analytical Method, HPLC, HPTLC, LC-MS, Hypertension, Telmisartan, UPLC, UV Spectrophotometry.

Downloads

Download data is not yet available.

Author Biographies

M. M. Eswarudu, Department of Pharmaceutical Analysis, Vignan Pharmacy College, Vadlamudi 522213, Andhra Pradesh, India

Department of Pharmaceutical Analysis, Vignan Pharmacy College, Vadlamudi 522213, Andhra Pradesh, India

P. Roja, Department of Pharmaceutical Analysis, Vignan Pharmacy College, Vadlamudi 522213, Andhra Pradesh, India

Department of Pharmaceutical Analysis, Vignan Pharmacy College, Vadlamudi 522213, Andhra Pradesh, India

P. Ravi Sankar, Department of Pharmaceutical Analysis, Vignan Pharmacy College, Vadlamudi 522213, Andhra Pradesh, India

Department of Pharmaceutical Analysis, Vignan Pharmacy College, Vadlamudi 522213, Andhra Pradesh, India

P. Srinivasa Babu, Department of Pharmaceutical Analysis, Vignan Pharmacy College, Vadlamudi 522213, Andhra Pradesh, India

Department of Pharmaceutical Analysis, Vignan Pharmacy College, Vadlamudi 522213, Andhra Pradesh, India

References

1. The Indian Pharmacopoeia, Government of India, Ministry of Health and Family welfare; 7th ed., The Indian pharmacopeia commission, Ghaziabad, 2018; II: 1304-1305,3319-3320.
2. Goodman and Gilman’s The pharmacological basis of therapeutics; 10th Edn; Medical publishing division, 2001; 1804.
3. Tripathi KD. Essentials of Medical Pharmacology; 6th ed., New Delhi, Jaypee Brothers Medical Publishers Ltd., 271-275.
4. The Indian Pharmacopoeia, Government of India, Ministry of Health and Family welfare; 7th ed., The Indian pharmacopeia commission, Ghaziabad, 2018; II: 1304-1305,3319-3320.
5. Japanese Pharmacopoeia, 17th Edition, The Ministry of Health Labour and Welfare, 2016; 704-707.
6. Drug Profile “Azelnidipine”, December,2020. http://www.drugbank.ca/drugs/DB09230.
7. Drug Profile, “Telmisartan”, December, 2020. http://www.drugbank.ca/drugs/DB00966.
8. Raskapur K.D. et al. UV-Spectrophotometric Method Development and Validation for determination of Azelnidipine in Pharmaceutical Dosage Form. International Journal of Pharmacy and Pharmaceutical Sciences. 2012; 4(1): 238-240.
9. Patel N., Patel J., et al., Simultaneous Determination of Azelnidipine and Olmesartan medoxomil by First Derivative Spectrophotometric Method: Scholars Research Library. 2012; 4(4): 1080-1084.
10. Rele R.V. et al. Spectrophotometric estimation of Azelnidipine in Bulk and Pharmaceutical Dosage form by Second Order Derivative Method. Journal of Chemical and Pharmaceutical Research. 2014; 6(8): 198-202.
11. Prabhakar D., Sreekanth J., Jayaveera KN., et al. Method Development and Validation of Azelnidipine by RP-HPLC: Int. J. of Chem.Tech. Research. 2017; 10(10): 418-423.
12. Gore M., Dabhade PS. RP-HPLC Method Development and Validation of Azelnidipine: Int. J. of Pharma. Sci. and Research. 2016;7(12): 5111-5114.
13. Kawabata K., Urasaki Y. Simultaneous determination of Azelnidipine and two metabolites in human plasma using liquid chromatography-tandem mass spectrometry: J. Chromatogr. B. 2006; 4(1): 45-52.
14. Amin A., Saad M., Amin et al. Simultaneous Determination of Azelnidipine and Olmesartan Medoxomil in Pharmaceutical Dosage Forms by UFLC Method: J. Of Pharma SciTech. 2016; 6(2): 69 -74.
15. Modi J., Patel SK., Parikh N., Shah S., Pradhan P., Upadhyay U., et al. Stability Indicating Analytical Method Development and Validation for Estimation of Azelnidipine: World J. of Pharma. Res. 2016; 5(2): 831-847.
16. Patel J., Patel N. Validated Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Azelnidipine and Olmesartan in Their Combined Dosage Form: Sci. Pharm. 2014; 4(1): 541–554.
17. Akshay S. Rane and Sunil K. Mahajan. Validation and Forced Stability-Indicating HPTLC Method for Determination of Azelnidipine: World Journal of Pharmaceutical Research.2016; 5(9), 1053-1062.
18. Suneetha et al. Sensitive Analysis of Azelnidipine and Related Derivative in Human Plasma by Ultra-Performance Liquid Chromatography-Tandam Mass Spectrometry: Asian J. of Chemistry. 2013; 15(18): 10319-10321.
19. Kawabata K, Samata N, Urasaki Y, Fukazawa I, Uchida N, Uchida E, Yasuhara H. Enantioselective determination of Azelnidipine in human plasma using liquid chromatography-tandem mass spectrometry. J Chromatogr B 2007; 852: 389-397.
20. Li Ding, Li Li, & amp; Pengcheng Ma. Determination of Azelnidipine in human plasma by liquid chromatography- electrospray ionization-mass spectrometry. J of Pharm Biomed Anal 2007; 43: 575-579.
21. Chitra Prabhu, Ganesa Sundararajan Subramanian, Arumugam Karthik. Determination of Telmisartan by HPTLC – A Stability Indicating Assay: Journal of Planar Chromatography. 2007; 6(14) :477–481.
22. Reema H. Rupareliya, Hitendra S. Joshi. Stability Indicating Simultaneous Validation of Telmisartan and Cilnidipine with Forced Degradation Behavior Study by RP-HPLC in Tablet Dosage Form. Hindawi Publishing Corporation ISRN Chromatography. 2013; 1–6.
23. Kaliappan Ilango, Pushpangadhan S. Shiji Kumar. Development and Validation of Stability Indicating HPTLC and HPLC Methods for Simultaneous Determination of Telmisartan and Atorvastatin in Their Formulations: Hindawi Publishing Corporation Journal of Chemistry. 2013; 1–9.
24. M. Lakshmi Surekha, G. Kumara Swamy, G. Lakshmi Ashwini. Development and Validation of RP - HPLC method for the estimation of Telmisartan in bulk and tablet dosage Form: International Journal of Drug Development & Research. 2012; 4 (4): 200-205.
25. RLC Shashidhar, S. Vidyadhara, B. Deepti, K. Tejaswi, J. Suhasini. Development and Validation of RP – HPLC Method for the Simultaneous Determination of Hydrochlorothiazide, Amlodipine Besylate and Telmisartan in Bulk and Pharmaceutical Formulation. Oriental Journal of Chemistry: 2014; 30 (4):1815-1822.
26. Bhoomi D. Patel, Ankit Chaudhary, Sudhir Gami. RP-HPLC Method Development and Validation for Simultaneous Estimation of Benidipine Hydrochloride, Telmisartan and Chlorthalidone in Tablet: Journal of Emerging Technologies and Innovative Research. 2019; 6 (3):110-124.
27. Jain Nilesh, Sharma Bhupendra Kumar, Jain Ruchi, Jain Deepak Kumar & Jain Surendra. RP-HPLC Method Development and Validation for Quantitative Estimation of Metoprolol Succinate and Telmisartan in Bulk Drug and Their Dosage Forms: Journal of Pharmaceutical and Biomedical Sciences.2012; 24 (24); 102-106.
28. Aashka Joshi, Dr. C. N. Patel. Stability Indicating Assay Method Development and Validation for Nebivolol and Telmisartan in its Combined Pharmaceutical Dosage Form: World Journal of Pharmaceutical Research.2018; 7(16):1006-1016.
29. Dharmendra Damor, Karan Mittal, Bhoomi Patel, Raja Shree Mashru. Method Development and Validation of Simultaneous Estimation of Cilostazol and Telmisartan: Journal of Pharmaceutical Analysis.2015; 4(3):41-48.
30. Niranjan D. Chivate, Siddharth M. Patil, Jagdish K. Saboji, Anuradha N. Chivate. Development of UV Spectrophotometric method for estimation and validation of Telmisartan as a pure API: Journal of Pharmacy Research. 2012; 5(6): 3331-3333.
31. Patel K, Patel A. Absorbance correction method for estimation of Telmisartan and Metoprolol succinate in combined tablet dosage forms: National Center for Biotechnology Information.2012; 3(2): 106-110.
32. Hirpara KP. Pave VM. UV-Spectrophotometric Determination for Simultaneous Estimation of Amlodipine Besylate and Telmisartan in Combination: J. of Pharma. Sci. and Bioscientific Research (JPSBR). 2012; 2(3): 133-137.
33. Modi M., Shah R., Mashru R C, et al. Development and Validation of Spectrophotometric methods for Simultaneous Estimation of Metoprolol Succinate and Telmisartan in Combined Pharmaceutical Formulation: Int. J. of Pharm. Science. 2012; 3(5):1348–1354.
34. Rathod S., Patil PM., Santosh SA. UV Spectrophotometric method development and Validation for Telmisartan in Bulk and Tablet Dosage Form: Int. J. of Pharm. Sci. and Res. 2012; 3(10): 3936-3939.
35. Kumar M., Kumar C., Bhatt S. Dissolution Method Development and Validation for Tablet Dosage form of Telmisartan Using UV Spectrophotometric Method: J. of Chem. and Pharm. Research. 2018; 10(5): 148-156.
36. Thakare C., Ahmed S., Shastry VM, et al. Development and validation of UV Visible Spectrophotometric Method for Estimation of Cilnidipine and Telmisartan in Bulk and Dosage Form: Indo American J. of Pharmaceutical research. 2017; 7(4): 8552–8555.
37. Jadhav RS, Ubale M. UV Spectrophotometric analytical method development and validation for determination of Telmisartan in Pharmaceutical Drug and Drug Product (Tablet dosage form): Int. J. of Current Advanced Research. 2018; 7(6):13292-13296.
38. Damor D., Patel B., Mittal K., Mashru R. Method Development and Validation of Simultaneous Estimation of Cilostazol and Telmisartan: Journal of Pharma. Analysis (JPA). 2015; 4(3): 41-48.
39. Nandipati S., Reddy V. Development and Validation of RP-HPLC Method for Estimation of Telmisartan in Bulk and Tablet Dosage Form: Int. Research J. of Pharma. and App.Sci. 2012; 2(3): 39-43.
40. Ashok P., Narendran ST. RP-HPLC method for estimation of Telmisartan in human plasma: Int. J. of App. Pharmaceutics. 2019; 2(1): 237 -240.
41. Kanaka L., Harshini S., Haque A. Analytical Method Development and Validation for the Simultaneous Estimation of Telmisartan and Hydrochlorothiazide by RP HPLC method in Bulk and Tablet Dosage Form: J. of Pharma. and Biomedical Analysis Letters (JPBMAL). 2016; 4(1): 1-8.
42. Palakunthi A., Dongala T. QbD based development of HPLC method for simultaneous quantification of Telmisartan and Hydrochlorothiazide impurities in tablets dosage form: Practical Laboratory Medicine. 2020; 21(3): 108-112.
43. Alhazmi A., Alnami H. A Fast and Validated Reversed-Phase HPLC Method for Simultaneous Determination of Simvastatin, Atorvastatin, Telmisartan and Irbesartan in Bulk Drugs and Tablet Formulations: Sci. Pharm. 2018; 2(1): 86-89.
44. Krishti A., Baraka, J., Dasvani B. Analytical Method Development and Validation of First Order Derivative Spectrophotometric Method for Simultaneous Estimation of Telmisartan and Metformin Hydrochloride in their Combined Pharmaceutical Dosage Form: Int. J. of Pharma. Quality Assurance (IJPQA). 2020; 11(1): 60-68.
45. Bangaruthali J., Harini V., Eswar N. Simultaneous estimation of Telmisartan and Atorvastatin calcium in API and tablet dosage form: J. of Drug Delivery and Therapeutics. 2019; 9(1): 175– 179.
46. Marolia B., Desai A. Development and Validation of HPTLC Method for Simultaneous Estimation of Amlodipine Besylate, Hydrochlorothiazide and Telmisartan in their Combined Tablet Dosage Form: Pharma Methods. 2016; 7(1): 48– 53.
47. BhadoriyaU., DhakedH., Upendra et al. RP-HPLC method Development and validation for estimation of Telmisartan in bulk and tablet dosage form: Int. J. of drug Reg. Affairs. 2013; 1(12): 61-64.
48. Prashanth Nallaveli et al. Analytical Method Development and Validation for the Simultaneous Estimation of Telmisartan and Atorvastatin in Bulk and Tablet Dosage Form: Int. J. of App. Pharma. Sci. and Res. 2020; 5(1): 312 -319.
49. Patel J., Dhingani A. Development and Validation of Bioanalytical HPLC Method for Estimation of Telmisartan in Rat Plasma: Application to Pharmacokinetic Studies: Dhaka Univ. J. Pharm. Sci. 2015; 11(2): 121-127.
50. Gayathri P., Goud S., Gayathri et al. Analytical Method Development and Validation for The Simultaneous Estimation of Metformin and Telmisartan in Bulk and Pharmaceutical Dosage Forms Using Rp-HPLC Method: World J. of Pharm. and Pharma.l Sci. 2015; 4(4): 753-762.
51. Sumaiya S., Bharadwaj A., Sumaiya S, et al. A Validated RP HPLC Method for Tablets Containing Amlodipine Besylate and Telmisartan Hcl as Active Pharmaceutical Ingredient: Mod Chem App. 2018; 8(3): 276 -279.
52. Kaur L., Singh G., Kaur, et al. Development and Validation of Rapid RP-HPLC Method for the Detection and Quantification of Telmisartan Incorporated in Dosage Forms and Plasma: J. of Pharmaceutical Research and Therapeutics. 2020; 1(2): 78-83.
53. Doshi Z., Shah J., Zeel T. Doshi et al. Development and Validation RP-HPLC Method for Simultaneous Estimation of Telmisartan and Nifedipine in Synthetic Mixture: Asian J. Pharma. Techno. & Innovation. 2016; 04(18): 01-10.
54. N.Vanaja, Ch. Preethi. Method Development and Validation for Simultaneous Estimation of Telmisartan and Chlorthalidone by RP-HPLC in Pharmaceutical Dosage Form: Asian J. Pharm. Ana. 2015; 5(4): 171 -177.
55. Patel RR et al. A New RP-HPLC method for simultaneous estimation of Telmisartan and Cilostazol in the synthetic mixture: Int. J. of Recent Sci. Res. 2015; 6(4): 3306-3310.
56. Barge VU, Gaikwad RB, Chaudhari FM. Development and Validation of Analytical Method for Simultaneous Estimation of Bisoprolol Fumarate and Telmisartan by Using RP HPLC Method: Int. J. of Pharma. and Clinical. Res. 2018; 10(8): 219-223.
57. Patra R., S. Mohan and N. Gowda, Patra et al. Stability-Indicating RP-UHPLC Method for Determination of Telmisartan in Drug Substance and Marketed Formulation: Int. J. of Pharma. Sci. and Res (IJPSR). 2016; 7(5): 2031-2039.
58. Kumar S., Venkateshwar R., Jupally T., Kumar M et al. Development and Validation of a Stability Indicating RP-HPLC Method for Simultaneous Determination of Telmisartan and Amlodipine in Combined Dosage form: Asian J. Pharm. Clin. Res. 2014; 7(1):32-35.
59. Sujana K, Gowri Sankar D, Bala Souri O, Swathi Rani G. Stability Indicating RPHPLC Method for the Determination of Telmisartan in Pure and Pharmaceutical Formulation: International Journal of Pharmacy and Pharmaceutical Sciences.2011;3(2): 164-167.
60. Gupta, R. M. Charde and M. S. Charde. Determination of Telmisartan and forced degradation behaviour by RP-HPLC in tablet dosage form: Journal of Pharmacy Research .2011;4(4):1270-1273.
61. Ch. Phani Kishore, V. Bhanu Prakash Reddy, Dhanashri M Kale. Development and validation of stability indicating HPLC method for the estimation of Telmisartan related substances in tablets formulation: International Journal of Research and Pharmaceutical Sciences.2010;1(4): 493-501.
62. D. Basava Chaitanya, M. Ajitha. Stability Indicating RP-HPLC Method Development and Validation for simultaneous estimation of Azelnidipine and Telmisartan in Bulk and Pharmaceutical Dosage Form: World Journal of Pharmaceutical Sciences.2022;10(01): 121-127.
63. Manish Kumar, Umesh Chandra, Arun Garg, Pankaj Gupta. Impurity profiling of Azelnidipine and Telmisartan in Fixed Dose Combination using Gradient RP-HPLC Method: Annals of the Romanian Society for Cell Biology.2021;25(4);15050-15067.
64. Ganduri R.B. et al. Stability Indicating Liquid Chromatographic Method for the Simultaneous Determination of Olmesartan and Azelnidipine in Combined Tablet Dosage form. International Journal of Pharma Sciences and Research. 2014; 5:275-282.
65. Kreya H. Patel and Rajvi J. Mahida. A Review on Analytical Methods for Estimation of Azelnidipine and Telmisartan in Pharmaceuticals: World Journal of Pharmaceutical Research.2021; 10(4): 589-604.
Statistics
73 Views | 49 Downloads
How to Cite
Eswarudu, M., Roja, P., Sankar, P., & Babu, P. (2022). An Updated Review On Analytical Methods For Estimation Of Azelnidipine And Telmisartan. Asian Journal of Pharmaceutical Research and Development, 10(2), 59-76. https://doi.org/https://doi.org/10.22270/ajprd.v10i2.1108